Budget expectation: Bring GST rate on APIs at par with the formulations
Express Pharma
JANUARY 12, 2024
There has been an amendment under income tax provisions to disallow such expenses incurred by pharmaceutical companies in violation of MCI regulations. – Due to the multiplicity of regulatory processes and multiple regulators, undertaking operations become complex and time consuming.
52 
Let's personalize your content